Anuncio
Anuncio

TXMD

TXMD logo

TherapeuticsMD, Inc.

2.17
USD
Patrocinado
+0.11
+5.15%
09 ene, 15:59 UTC -5
Cerrado
exchange

Post-mercado

2.12

-0.05
-2.12%

Informes de beneficios de TXMD

Ratio de Sorpresa Positivo

TXMD superó 15 de las últimas 32 estimaciones.

47%

Próximo informe

Fecha del próximo informe
25 mar 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
--
Cambio implícito desde Q3 25 (Revenue/ EPS)
--
/
--
Cambio implícito desde Q4 24 (Revenue/ EPS)
--
/
--

TherapeuticsMD, Inc. earnings per share and revenue

On 12 nov 2025, TXMD reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Preguntas frecuentes
For Q3 2025, TherapeuticsMD, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for 25 mar 2026.
Based on -- analistas, TherapeuticsMD, Inc. is expected to report EPS of -- and revenue of -- for Q4 2025.
Cheque FXEmpire's Earnings Calendar for today's list of reporting companies.
Anuncio